Kelly Thomas
About Kelly Thomas
Kelly Thomas serves as the Head of Quality Assurance at Veru Inc., bringing over 20 years of experience in quality management and regulatory compliance across various pharmaceutical companies.
Current Role at Veru
Kelly Thomas serves as the Head of Quality Assurance at Veru Inc. since 2021. In this role, she is responsible for overseeing quality assurance processes and ensuring compliance with regulatory standards. Her leadership focuses on maintaining high-quality systems and fostering a culture of continuous improvement within the organization.
Previous Experience in Quality Assurance
Prior to her current position, Kelly held several key roles in quality assurance across various organizations. She was the Senior Director of Quality Assurance and Quality Control at Stallergenes Greer from 2017 to 2018, and later served as Vice President of Americas Quality Operations from 2018 to 2021. Her earlier experience includes positions at Covidien, Glenmark Pharmaceuticals, Sandoz, Amgen, and bioMerieux, where she developed her expertise in quality management and regulatory compliance.
Education and Expertise
Kelly Thomas earned her Master of Business Administration (MBA) from Meredith College, studying from 2000 to 2003. She also holds a Bachelor of Science degree in Biology from East Carolina University, which she completed from 1995 to 1998. Her educational background supports her extensive experience in quality assurance and regulatory compliance.
Skills and Specializations
Kelly has over 20 years of experience in quality assurance, specializing in Lean Six Sigma programs, global regulatory compliance, and quality systems development. She has a proven track record in leading facility start-ups, conducting cGMP surveillance inspections, and implementing effective contract manufacturing and supplier management programs. Her strengths include motivating teams, developing budgets, and establishing clear Key Performance Metrics (KPIs).
Regulatory Compliance Experience
Kelly has significant experience with global regulatory compliance, having participated in inspections by various regulatory bodies, including the FDA, EMEA, IMB, JP, Health Canada, and ANVISA. Her expertise in this area enhances her ability to lead quality assurance initiatives and ensure adherence to industry standards.